Chaddock JA - Search Results

1

Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity.

Fonfria E, Elliott M, Beard M, Chaddock JA, Krupp J. Fonfria E, et al. Among authors: chaddock ja. Toxins (Basel). 2018 Jul 4;10(7):278. doi: 10.3390/toxins10070278. Toxins (Basel). 2018. PMID: 29973505 Free PMC article. Review.

2

Engineering botulinum neurotoxin domains for activation by toxin light chain.

Stancombe PR, Masuyer G, Birch-Machin I, Beard M, Foster KA, Chaddock JA, Acharya KR. Stancombe PR, et al. Among authors: chaddock ja. FEBS J. 2012 Feb;279(3):515-23. doi: 10.1111/j.1742-4658.2011.08444.x. Epub 2011 Dec 23. FEBS J. 2012. PMID: 22141396 Free article.

3

Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B.

Masuyer G, Beard M, Cadd VA, Chaddock JA, Acharya KR. Masuyer G, et al. Among authors: chaddock ja. J Struct Biol. 2011 Apr;174(1):52-7. doi: 10.1016/j.jsb.2010.11.010. Epub 2010 Nov 13. J Struct Biol. 2011. PMID: 21078393 Free article.

4

Engineering toxins for 21st century therapies.

Chaddock JA, Acharya KR. Chaddock JA, et al. FEBS J. 2011 Apr;278(6):899-904. doi: 10.1111/j.1742-4658.2011.08013.x. Epub 2011 Feb 3. FEBS J. 2011. PMID: 21382174 Free article.

5

Transforming the domain structure of botulinum neurotoxins into novel therapeutics.

Chaddock J. Chaddock J. Curr Top Microbiol Immunol. 2013;364:287-306. doi: 10.1007/978-3-642-33570-9_13. Curr Top Microbiol Immunol. 2013. PMID: 23239358 Review.

6

Structural analysis of Clostridium botulinum neurotoxin type D as a platform for the development of targeted secretion inhibitors.

Masuyer G, Davies JR, Moore K, Chaddock JA, Ravi Acharya K. Masuyer G, et al. Among authors: chaddock ja. Sci Rep. 2015 Sep 1;5:13397. doi: 10.1038/srep13397. Sci Rep. 2015. PMID: 26324071 Free PMC article.

7

Botulinum neurotoxin A and neurotoxin E cleavage products of synaptosome-associated protein of 25 kd exhibit distinct actions on pancreatic islet beta-cell Kv2.1 channel gating.

He Y, Elias CL, Huang YC, Gao X, Leung YM, Kang Y, Xie H, Chaddock JA, Tsushima RG, Gaisano HY. He Y, et al. Among authors: chaddock ja. Pancreas. 2008 Jan;36(1):10-7. doi: 10.1097/mpa.0b013e31812eee28. Pancreas. 2008. PMID: 18192874

8

Engineered botulinum neurotoxins as new therapeutics.

Masuyer G, Chaddock JA, Foster KA, Acharya KR. Masuyer G, et al. Among authors: chaddock ja. Annu Rev Pharmacol Toxicol. 2014;54:27-51. doi: 10.1146/annurev-pharmtox-011613-135935. Epub 2013 Aug 30. Annu Rev Pharmacol Toxicol. 2014. PMID: 24016211 Review.

9

Expression and purification of catalytically active, non-toxic endopeptidase derivatives of Clostridium botulinum toxin type A.

Chaddock JA, Herbert MH, Ling RJ, Alexander FC, Fooks SJ, Revell DF, Quinn CP, Shone CC, Foster KA. Chaddock JA, et al. Protein Expr Purif. 2002 Jul;25(2):219-28. doi: 10.1016/s1046-5928(02)00002-5. Protein Expr Purif. 2002. PMID: 12135553

10

Clostridial neurotoxins: structure-function led design of new therapeutics.

Chaddock JA, Marks PM. Chaddock JA, et al. Cell Mol Life Sci. 2006 Mar;63(5):540-51. doi: 10.1007/s00018-005-5505-5. Cell Mol Life Sci. 2006. PMID: 16416025 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page